SLU-PP-332: Reference Overview and Reconstitution Notes

SLU-PP-332 research image
For research and educational reference only. Preppin Peppers sells laboratory hardware and materials (reconstitution pens, cartridges, and bacteriostatic water); it does not sell peptides or any substance for consumption. This is educational content, not medical, health, veterinary, dosing, or compounding advice, has not been evaluated by the FDA, and is not intended to diagnose, treat, cure, or prevent any condition, or for human or animal use. Comply with the laws that apply to you and consult a licensed professional for any health decision.

SLU-PP-332 is a lab-made chemical compound. Researchers use it to study a group of proteins called ERRs (estrogen-related receptors), which help control how cells produce and use energy. It falls under the metabolic and exercise-physiology research category. It is research-only and not approved by the FDA.

SLU-PP-332


What it is

Chemical structure of SLU-PP-332
The chemical structure of SLU-PP-332.

SLU-PP-332 is a man-made chemical compound. Scientists created it as a research tool to study proteins called estrogen-related receptors (ERRs). These proteins help control how cells make and use energy.

Some suppliers list it alongside peptides (short chains of amino acids). But SLU-PP-332 is not a peptide. It is a small synthetic molecule built entirely in a lab. It works by switching on three types of ERR proteins: ERR-alpha, ERR-beta, and ERR-gamma. A compound that switches a receptor on like this is called an agonist. Because SLU-PP-332 activates all three types, it is called a pan-agonist ("pan" means "all").


Research context and categorization

SLU-PP-332 is studied in two areas: metabolism (how the body turns food into energy) and exercise physiology (how the body responds to physical activity). Researchers often describe it as a candidate "exercise mimetic," meaning a compound that may copy some of the changes the body goes through during exercise.

The ERR proteins it targets are involved in three key processes inside cells. First, mitochondrial biogenesis: building new mitochondria, which are the tiny parts of a cell that produce energy (think of them as miniature power plants). Second, oxidative phosphorylation: the main way cells generate energy using oxygen. Third, fatty acid metabolism: how cells break down fat for fuel. These connections are why SLU-PP-332 is studied in a metabolic-research setting.

Preclinical findings

Most research so far has been done in mouse models (laboratory mice). In those studies, SLU-PP-332 has been examined for its effects on muscle fiber type (specifically the slow-twitch, fatigue-resistant fibers that endurance athletes rely on), fat burning, and stamina.

It has also been explored in research on metabolic syndrome (a set of conditions linked to poor energy regulation) and obesity. Much of the discussion focuses on whether the compound can reproduce some of the metabolic changes that happen in the body during endurance exercise.

Key point: SLU-PP-332 is strictly investigational (still in early-stage research). No completed human clinical trials exist. None of the effects described have been confirmed or approved in humans. All of this should be read as research information, not as established benefits.


Status

  • Regulatory status: Research-only / not FDA-approved. SLU-PP-332 has no approved human use. It is handled as a laboratory research chemical.
  • Sport status: Banned under the WADA Prohibited List (the global anti-doping rules). SLU-PP-332 is not listed by name, but it fits into the banned category of hormone and metabolic modulators (WADA class S4), which covers ERR agonists and similar compounds. Anti-doping labs have already published research on how to detect it in tests. Any athlete subject to doping controls should treat it as prohibited at all times.

Reconstitution notes (general)

When a research powder is lyophilized (freeze-dried), you add liquid to dissolve it. The concentration you get equals the milligrams of compound in the vial divided by the millilitres of liquid you add. Think of it like mixing a powdered drink: the more liquid you add, the more dilute the result.

For example, dissolving a given amount of compound in a chosen volume of bacteriostatic water (sterile water with a small preservative added) gives you a concentration in milligrams per millilitre. To work out a specific number, use the calculator at peptide calculator.


Dilution and handling notes (compound-specific)

SLU-PP-332 has one important property that sets it apart from most water-soluble peptides: it has poor aqueous solubility, meaning it does not dissolve easily in water.

When you try to dissolve it in bacteriostatic water alone, it often stays cloudy, becomes gel-like, or leaves undissolved bits in the vial. This problem gets worse at higher concentrations.

Solvent and preparation guidance

Because of this, lab and supplier guides commonly recommend dissolving SLU-PP-332 in an organic solvent (a type of liquid that can dissolve things water cannot). A widely used choice is DMSO (dimethyl sulfoxide), a solvent found in many research labs.

Some preparation steps call for adding a small amount of DMSO or ethanol first to get the compound fully dissolved, before adding any other liquid. In practice, this means researchers use a modest volume of liquid per vial and swirl the solution gently rather than shaking it hard.

If the solution stays cloudy or shows small particles after mixing, that usually reflects the compound's limited ability to dissolve in water. It does not necessarily mean contamination. Adding a co-solvent (a helper solvent like DMSO) is the standard way researchers handle this.

Some suppliers also offer SLU-PP-332 as an oral capsule. If you have capsules rather than a freeze-dried powder, there is nothing to dissolve and these steps do not apply. In short: treat the powder form as a small-molecule solubility challenge, not as a standard water-based peptide reconstitution.


Handling and storage

Store any reconstituted (dissolved) material in a refrigerator at 2 to 8 C, away from direct light. Before accessing the vial, wipe the stopper with alcohol and write the mixing date on the label.

A reconstituted solution is generally considered usable for about a four-week refrigerated window. Sealed, unopened freeze-dried vials are more stable and are best kept frozen for longer-term storage.

Discard any solution that becomes cloudy in a way that does not match the compound's known solubility behavior, or that shows discoloration or floating particles. These can be signs of degradation (breakdown of the compound) or contamination.



Tools and supplies

Macro of SLU-PP-332 lyophilized powder
Close detail of the lyophilized powder.

Reminder: research and educational reference only. Preppin Peppers sells hardware and materials, not peptides. Not medical, dosing, or health advice, not evaluated by the FDA, and not intended for human or animal use.



Frequently asked questions

Is SLU-PP-332 a peptide?

No. Despite appearing in some peptide supplier catalogs, SLU-PP-332 is a small synthetic molecule, not a peptide (chain of amino acids). It is an entirely lab-made chemical compound.

How does SLU-PP-332 work at the molecular level?

It acts as a pan-agonist, activating all three estrogen-related receptors (ERRα, ERRβ, ERRγ), which regulate mitochondrial biogenesis, oxidative phosphorylation, and fatty acid metabolism in cells.

Is SLU-PP-332 banned in sport?

Yes. Though not named individually, it fits WADA class S4 (hormone and metabolic modulators), which covers ERR agonists. Anti-doping labs have published detection methods; athletes should treat it as prohibited.

What the research community gets wrong about SLU-PP-332

A few habits carry over from peptide work that do not fit this compound. Here is what trips people up at the bench.

  • It is not a peptide, so peptide reconstitution habits do not transfer. SLU-PP-332 shows up in some peptide catalogs, but it is a small synthetic molecule, not a chain of amino acids. Treat the powder as a small-molecule solubility problem, not a routine water mix.
  • A cloudy vial is usually poor water solubility, not contamination. Many researchers expect a clear solution the way most peptides give one. This compound dissolves poorly in water, so haze, gel, or leftover bits often just reflect that. A co-solvent like DMSO is the common way labs get it into solution.
  • The label concentration may not match what actually dissolved. Concentration on paper is milligrams divided by millilitres, but if part of the powder stays undissolved in plain water, the real amount in solution can be lower than the number you wrote down.
  • "Exercise mimetic" describes animal studies, not a proven human result. The published work is mostly in mouse models. Calling it an exercise mimetic is a research label for what it did in those studies, not a confirmed effect in people.
  • Being unlisted by name does not mean it is allowed in sport. It is not named individually on the WADA Prohibited List, but it fits the class that covers ERR agonists (metabolic modulators), and anti-doping labs have already published ways to detect it.

From our bench: If you have prepared SLU-PP-332 powder, tell us what you saw when it met liquid. At roughly what concentration in plain bacteriostatic water did it start to stay cloudy or leave undissolved bits, and did switching to a DMSO co-solvent give you a clear solution? Share the exact volumes and concentrations you measured (not estimates), and we will add real bench observations to this page.


Sources

  1. Bacteriostatic Water for Injection, USP , FDA/DailyMed label (0.9% benzyl alcohol)
  2. Duerkop et al., Biotechnol J 2018 , Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation
  3. Sigma-Aldrich (Merck) , Handling and Storage Guidelines for Peptides and Proteins
  4. PubChem CID 5338394: SLU-PP-332 (compound record, C18H14N2O2)
  5. Billon et al., ACS Chem Biol 2023 , Synthetic ERRα/β/γ Agonist Induces an ERRα-Dependent Acute Aerobic Exercise Response and Enhances Exercise Capacity (PMID 36988910)
  6. Billon et al., J Pharmacol Exp Ther 2024 , A Synthetic ERR Agonist Alleviates Metabolic Syndrome (PMID 37739806)

✔ Reviewed by Bryan Le, PharmD, RPh

Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.

Get more of The Lab in your Google results
Browse The Lab by topic